Immunovant, Inc.IMVTNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P90
Near historical high
vs 2Y Ago
33x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 13.21% |
| Q3 2025 | -3.57% |
| Q2 2025 | -11.77% |
| Q1 2025 | 0.42% |
| Q4 2024 | 1.24% |
| Q3 2024 | -22.76% |
| Q2 2024 | -16.57% |
| Q1 2024 | -31.40% |
| Q4 2023 | 0.40% |
| Q3 2023 | 6.33% |
| Q2 2023 | -2.67% |
| Q1 2023 | -18.94% |
| Q4 2022 | -8.89% |
| Q3 2022 | -22.88% |
| Q2 2022 | 14.51% |
| Q1 2022 | -14.43% |
| Q4 2021 | -9.62% |
| Q3 2021 | -25.98% |
| Q2 2021 | -3.35% |
| Q1 2021 | 8.61% |
| Q4 2020 | -50.85% |
| Q3 2020 | 21.11% |
| Q2 2020 | -29.80% |
| Q1 2020 | -85.52% |
| Q4 2019 | -2530.33% |
| Q3 2019 | -354.57% |
| Q2 2019 | -20420.44% |
| Q1 2019 | 99.99% |
| Q4 2018 | -42.38% |
| Q3 2018 | -42.84% |
| Q2 2018 | 0.00% |